Optimizing adalimumab treatment in psoriasis with concomitant methotrexate: a randomized controlled trial

被引：0
|
作者：
Van der Kraaij, G. [1 ,2 ]
Busard, C. [1 ]
van den Reek, J. [3 ]
Menting, S. [1 ]
de Jong, E. [3 ,4 ]
de Kort, W. [5 ]
Lambert, J. [6 ]
Spuls, P. [1 ,2 ]
机构：
[1] Amsterdam UMC, Dermatol, Amsterdam, Netherlands
[2] Amsterdam UMC, Publ Hlth, Amsterdam, Netherlands
[3] Radboud UMC, Dermatol, Nijmegen, Netherlands
[4] Univ Nijmegen, Nijmegen, Netherlands
[5] Amphia Ziekenhuis, Dermatol, Breda, Netherlands
[6] UZ Gent, Dermatol, Ghent, Belgium
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷
关键词：
Adalimumab; Drug survival; Psoriasis; ANTIBODY;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P043
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [21] Adalimumab vs Methotrexate for the Treatment of Chronic Plaque Psoriasis In reply
    Saurat, Jean-Hilaire
    ARCHIVES OF DERMATOLOGY, 2009, 145 (06) : 706 - 706
  • [22] Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial
    Soufila KT
    Vishal Thakur
    Tarun Narang
    Sunil Dogra
    Sanjeev Handa
    American Journal of Clinical Dermatology, 2021, 22 : 415 - 423
  • [23] Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial
    Soufila, K. T.
    Thakur, Vishal
    Narang, Tarun
    Dogra, Sunil
    Handa, Sanjeev
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (03) : 415 - 423
  • [24] A randomized controlled trial to compare the efficacy and safety of apremilast and methotrexate in patients with palmoplantar psoriasis
    Soufila, K. T.
    Thakur, V.
    Narang, T.
    Dogra, S.
    Handa, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 9 - 9
  • [25] Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial
    Maari, Catherine
    Bolduc, Chantal
    Nigen, Simon
    Marchessault, Philippe
    Bissonnette, Robert
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2014, 25 (01) : 57 - 60
  • [26] The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial
    de Jong, EMGJ
    Mork, NJ
    Seijger, MMB
    De la Brassine, M
    Lauharanta, J
    Jansen, CT
    Guilhou, JJ
    Guillot, B
    Ostrojic, A
    Souteyrand, P
    Vaillant, L
    Barnes, L
    Rogers, S
    Klaber, MR
    van de Kerkhof, PCM
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (02) : 318 - 325
  • [27] Broadband ultraviolet A in the treatment of psoriasis vulgaris: a randomized controlled trial
    El-Mofty, Medhat
    Mostafa, Wedad Z.
    Yousef, Randa
    Halim, Mona R. E. Abdel
    El Hawary, Marwa
    Kader, Hanaa Abdel
    Assaad, Soheir
    Ghannam, Bahaa B.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (09) : 1157 - 1164
  • [28] CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis A Randomized Clinical Trial
    Goldminz, Ari M.
    Suarez-Farinas, Mayte
    Wang, Andrew C.
    Dumont, Nicole
    Krueger, James G.
    Gottlieb, Alice B.
    JAMA DERMATOLOGY, 2015, 151 (08) : 837 - 846
  • [29] Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial
    Salim, A.
    Tan, E.
    Ilchyshyn, A.
    Berth-Jones, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (06) : 1169 - 1174
  • [30] Efficacy of adalimumab compared with methotrexate or placebo stratified by baseline BMI in a randomized, placebo-controlled trial
    Prussick, Ronald B.
    Unnebrink, Kristina
    Ghorayeb, Eric
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB233 - AB233
12345